Medicamen Biotech Ltd.

Financial

	Medicamen Biotech	Fredun Pharma	Albert David
Operational Metrics
Financials
5 yr Average ROE	8.49 %	8.53 %	11.47 %
5yr average Equity Multiplier	1.47	3.02	1.63
5yr Average Asset Turnover Ratio	0.58	1.01	0.62
5yr Avg Net Profit Margin	10.0 %	2.89 %	11.31 %
Price to Book	2.26	3.49	1.19
P/E	50.58	21.09	74.08
5yr Avg Cash Conversion Cycle	13.14 Days	137.13 Days	-77.77 Days
Inventory Days	66.66 Days	140.46 Days	47.91 Days
Days Receivable	122.66 Days	52.11 Days	27.87 Days
Days Payable	257.34 Days	131.93 Days	140.35 Days
5yr Average Interest Coverage Ratio	10.36	2.31	93.73
5yr Avg ROCE	12.12 %	16.75 %	14.69 %
5yr Avg Operating Profit Margin	16.84 %	8.32 %	9.55 %
5 yr average Debt to Equity	0.14	0.86	0.02
5yr CAGR Net Profit	-6.51 %	52.4 %	-4.92 %
5yr Average Return on Assets	5.75 %	3.05 %	7.03 %
Shareholdings
Promoter Holding	40.46 %	48.93 %	62.24 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.14 %	-2.11 %	0.25 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Medicamen Biotech	Fredun Pharma	Albert David
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals Formulations 100.0 0 Pharmaceuticals 0	Product Wise Break-Up Pharmaceutical 100.0 Pharmaceuticals 0 Pharmaceuticals Formulations 0	Product Wise Break-Up 0 Pharmaceutical 100.0 Pharmaceuticals Formulations 0
Location Wise Break-Up	Location Wise Break-Up India 20.0 Rest of the World 0 Others 80.0	Location Wise Break-Up Rest of the World 22.32 India 77.22 Others 0.46	Location Wise Break-Up Rest of the World 6.76 India 93.24